HK1171682A1 - 鼻炎治療劑 - Google Patents

鼻炎治療劑

Info

Publication number
HK1171682A1
HK1171682A1 HK12112567.4A HK12112567A HK1171682A1 HK 1171682 A1 HK1171682 A1 HK 1171682A1 HK 12112567 A HK12112567 A HK 12112567A HK 1171682 A1 HK1171682 A1 HK 1171682A1
Authority
HK
Hong Kong
Prior art keywords
rhinitis
therapeutic agent
therapeutic
agent
Prior art date
Application number
HK12112567.4A
Other languages
English (en)
Inventor
Kyoko Endo
Original Assignee
Kyoko Endo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyoko Endo filed Critical Kyoko Endo
Publication of HK1171682A1 publication Critical patent/HK1171682A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2242—Atrial natriuretic factor complex: Atriopeptins, atrial natriuretic protein [ANP]; Cardionatrin, Cardiodilatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
HK12112567.4A 2009-08-27 2012-12-05 鼻炎治療劑 HK1171682A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2009197488 2009-08-27
PCT/JP2010/064644 WO2011024973A1 (ja) 2009-08-27 2010-08-27 鼻炎治療剤

Publications (1)

Publication Number Publication Date
HK1171682A1 true HK1171682A1 (zh) 2013-04-05

Family

ID=43628070

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12112567.4A HK1171682A1 (zh) 2009-08-27 2012-12-05 鼻炎治療劑

Country Status (15)

Country Link
US (4) US20130045921A1 (zh)
EP (1) EP2471546B1 (zh)
JP (1) JP4790096B2 (zh)
KR (2) KR20130001337A (zh)
CN (1) CN102596216B (zh)
AU (1) AU2010287421B2 (zh)
BR (1) BR112012004058A2 (zh)
CA (1) CA2771215C (zh)
DK (1) DK2471546T3 (zh)
ES (1) ES2556336T3 (zh)
HK (1) HK1171682A1 (zh)
MX (1) MX2012002175A (zh)
NZ (1) NZ598600A (zh)
RU (1) RU2502519C2 (zh)
WO (1) WO2011024973A1 (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2457581T3 (da) 2009-07-23 2014-03-31 Igisu Co Ltd Sammensætning omfattende CNP eller BNP for et udvendigt præparat til hud til behandling af dermatitis
BR112012004058A2 (pt) 2009-08-27 2021-08-17 Kyoko Endo preparação terapêutica para rinite
HUE035584T2 (en) * 2011-01-21 2018-05-28 Igisu Co Ltd A therapeutic agent for the treatment of allopathy
EP2794646A4 (en) * 2011-12-23 2015-12-09 Mayo Foundation ASSESSMENT OF STRUCTURAL CHANGES AND RESULTS OF THE KIDNEYS
CN107709352A (zh) * 2015-05-29 2018-02-16 Igisu株式会社 环肽以及含有该环肽的药物、外用剂和化妆品
EP3330280A4 (en) * 2015-07-31 2019-06-12 Igisu Co., Ltd. CYCLIC PEPTIDE CNP AND MEDICINE, PREPARATION FOR EXTERNAL USE AND COSMETIC PRODUCT, CONTAINING ALL OF SAID CYCLIC PEPTIDE
DK3331498T3 (da) * 2015-08-04 2020-06-15 Windstar Medical Gmbh Nasalsammensætning
CN105617360B (zh) * 2015-12-04 2018-12-21 中国农业大学 C-型钠肽在制备外用避孕药和精子功能检测试剂中的应用
WO2018173971A1 (ja) 2017-03-21 2018-09-27 Ｗｅｌｌ Ｓｔｏｎｅ 有限会社 点鼻剤組成物の製造方法、及び、点鼻剤組成物
US10959992B2 (en) 2019-02-22 2021-03-30 Bridge Pharma Inc. Methods of treatment of asthma and COPD
US20200268734A1 (en) * 2019-02-22 2020-08-27 Bridge Pharma, Inc. Methods of treatment of respiratory disorders
CN112057478A (zh) * 2020-10-16 2020-12-11 常州市艾斯康生物医药有限公司 一种用于舒缓和预防过敏性鼻炎的药物制剂
KR102677730B1 (ko) * 2023-03-27 2024-06-27 나인바이오팜 주식회사 지방 분해 효능을 갖는 펩타이드 및 이의 용도

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1339210C (en) * 1988-05-31 1997-08-05 John Lewicki Recombinant techniques for production of novel natriuretic and vasodilator peptides
US5114923A (en) 1988-05-31 1992-05-19 California Biotechnology Inc. Recombinant techniques for production of novel natriuretic and vasodilator peptides
JP2809533B2 (ja) 1991-01-31 1998-10-08 壽之 松尾 Ｃｎｐ類似体ペプチド
JPH05207891A (ja) 1991-03-08 1993-08-20 Shionogi & Co Ltd 脳性ナトリウム利尿ペプチドの製造方法
AU6360394A (en) 1993-03-03 1994-09-26 Mayo Foundation For Medical Education And Research Vasonatrin peptide and analogs thereof
US6028055A (en) 1996-10-22 2000-02-22 Genetech, Inc. Receptor selective BNP
US5965533A (en) 1997-05-23 1999-10-12 Baxter International Inc. Atrial natriuretic peptide (ANP) as an additive to peritoneal dialysis solutions
JP3799465B2 (ja) 1998-09-28 2006-07-19 参天製薬株式会社 ナトリウム利尿ペプチドを有効成分とする涙液分泌促進または角結膜障害治療用点眼剤
WO2000018422A1 (fr) 1998-09-28 2000-04-06 Santen Pharmaceutical Co., Ltd. Promoteurs de secretion lacrymale ou gouttes ophtalmologiques contenant des peptides natriuretiques comme principes actifs pour traiter la keratoconjonctivite
US6407211B1 (en) * 1999-12-17 2002-06-18 Mayo Foundation For Medical Education And Research Chimeric natriuretic peptides
JP3676707B2 (ja) * 2001-07-18 2005-07-27 三菱電機株式会社 車両用交流発電機の固定子およびその製造方法
US7655772B2 (en) * 2002-09-06 2010-02-02 University Of South Florida Materials and methods for treatment of allergic diseases
US20050271596A1 (en) 2002-10-25 2005-12-08 Foamix Ltd. Vasoactive kit and composition and uses thereof
BRPI0411410A (pt) 2003-06-13 2006-07-25 Daiichi Asubio Pharma Co Ltd composições farmacêuticas para a prevenção ou tratamento de doenças imunes mediadas por th1
JP4881156B2 (ja) 2003-06-20 2012-02-22 メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ 脳性ナトリウム利尿ペプチドのアイソフォーム
AU2005207886A1 (en) 2004-01-27 2005-08-11 Compugen Usa, Inc. Novel brain natriuretic peptide variants and methods of use thereof
JP2007525213A (ja) 2004-01-27 2007-09-06 コンピュゲン ユーエスエイ，インク． 新規の脳性ナトリウム利尿ペプチドの変異体及びその利用方法
CA2561530C (en) * 2004-03-31 2014-04-22 Kazuwa Nakao Therapeutic or prophylactic agent for arthritis
EP3620530A1 (en) 2004-03-31 2020-03-11 Kazuwa Nakao Composition for increasing body height
MX2007001667A (es) 2004-08-11 2007-10-02 Johnson & Johnson Aparato y metodo para el suministro transdermico de peptidos natriureticos.
DE102004048576A1 (de) 2004-10-04 2006-04-13 Deutsches Zentrum für Luft- und Raumfahrt e.V. Methode zur Bräunung der Haut
EP1810716A1 (de) 2005-12-23 2007-07-25 Deutsches Zentrum für Luft- und Raumfahrt e.V. Verfahren zur Bräunung der Haut
CA2656990A1 (en) * 2006-04-28 2007-11-08 University Of South Florida Materials and methods for reducing inflammation by inhibition of the atrial natriuretic peptide receptor
CN101501067B (zh) 2006-08-08 2013-01-16 梅约医学教育与研究基金会 利尿和利尿钠的多肽
JP2010502231A (ja) * 2006-09-08 2010-01-28 メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ 血管拡張作用を欠く水利尿およびナトリウム利尿ポリペプチド
WO2008032450A1 (fr) 2006-09-15 2008-03-20 Kyoto University Agent prophylactique et/ou thérapeutique pour une stéatose hépatique
JP5010913B2 (ja) 2006-12-31 2012-08-29 寿子 小出 心房利尿ホルモンファミリー分子を活性物質として含有する組織再生製剤また該製剤をもちいる組織再生方法、および心房利尿ホルモンファミリー分子を活性物質として含有する発毛、増毛、育毛剤および皮膚組織修復改善剤また該製剤を用いる発毛、増毛、育毛促進方法および皮膚組織修復改善方法
JP2010168283A (ja) 2007-04-24 2010-08-05 Yamaguchi Univ ナトリウム利尿ペプチドを有効成分とする肝硬変・前癌病変の抑制剤
WO2008140125A1 (ja) 2007-05-10 2008-11-20 National University Corporation Nagoya University 腹膜線維化抑制用医薬組成物
RU2010114017A (ru) * 2007-09-11 2011-10-20 Мондобайотек Лабораториз Аг (Li) Терапевтическое применение натрийуретического пептида в-типа и гормона роста человека 1-43
US20100323950A1 (en) 2007-09-11 2010-12-23 Dorian Bevec Use of beta-melanotropin as a therapeutic agent, eg for the treatment of aids or alzheimer
AR069409A1 (es) 2007-11-21 2010-01-20 Biomarin Pharm Inc Variantes de peptidos natriureticos de tipo c
WO2010048308A2 (en) * 2008-10-24 2010-04-29 Deborah Dickey Natriuretic polypeptides
WO2010078325A2 (en) * 2008-12-29 2010-07-08 Mayo Foundation For Medical Education And Research Natriuretic polypeptides for reducing or preventing restenosis
HUE057174T2 (hu) * 2009-05-20 2022-04-28 Biomarin Pharm Inc A C-típusú nátriuretikus peptid variánsai
BR112012004058A2 (pt) 2009-08-27 2021-08-17 Kyoko Endo preparação terapêutica para rinite

Also Published As

Publication number Publication date
RU2502519C2 (ru) 2013-12-27
CA2771215A1 (en) 2011-03-03
US20140243271A1 (en) 2014-08-28
AU2010287421A1 (en) 2012-04-05
CN102596216A (zh) 2012-07-18
NZ598600A (en) 2014-03-28
EP2471546A4 (en) 2013-02-20
CN102596216B (zh) 2016-04-20
US20130045921A1 (en) 2013-02-21
RU2012105046A (ru) 2013-10-10
US20170007673A1 (en) 2017-01-12
BR112012004058A2 (pt) 2021-08-17
KR20130001337A (ko) 2013-01-03
EP2471546A1 (en) 2012-07-04
JPWO2011024973A1 (ja) 2013-01-31
EP2471546B1 (en) 2015-11-25
AU2010287421B2 (en) 2013-06-13
MX2012002175A (es) 2012-06-27
US11452762B2 (en) 2022-09-27
JP4790096B2 (ja) 2011-10-12
WO2011024973A1 (ja) 2011-03-03
US9358270B2 (en) 2016-06-07
KR101229546B1 (ko) 2013-02-05
DK2471546T3 (en) 2016-01-25
US9962429B2 (en) 2018-05-08
ES2556336T3 (es) 2016-01-15
CA2771215C (en) 2013-01-22
US20180318395A1 (en) 2018-11-08
KR20120060219A (ko) 2012-06-11

Similar Documents

Publication Publication Date Title
HK1171682A1 (zh) 鼻炎治療劑
GB0908957D0 (en) Therapeutic agents
IL214919A0 (en) Method for therapeutic use
AP3250A (en) Tablets for combination therapy
ZA201100904B (en) Therapeutic agent for migraine
HRP20171418T1 (hr) Terapeutsko sredstvo za poremećaje anksioznosti
EP2510949A4 (en) THERAPEUTICS FOR FIBROMYALGIA
EP2427183A4 (en) THERAPEUTIC COMPOUNDS
GB0900484D0 (en) Therapeutic agent
EP2496704A4 (en) THERAPEUTIC COMPOUNDS
GB0910493D0 (en) Therapeutic agents
EP2456309A4 (en) THERAPEUTIC COMPOUNDS
GB0906026D0 (en) Therapeutic compounds
GB0919819D0 (en) Therapeutic agents
GB0919821D0 (en) Therapeutic agents
GB0919829D0 (en) Therapeutic agents
GB0902450D0 (en) Therapeutic agents
GB0907971D0 (en) Therapeutic agents
GB0919820D0 (en) Therapeutic agents
GB0915586D0 (en) Therapeutic agents
GB0914533D0 (en) Therapeutic agents
GB0903949D0 (en) Therapeutic agents
GB0919824D0 (en) Therapeutic agents
GB0919825D0 (en) Therapeutic agents
GB0911965D0 (en) Therapeutic agents